USD 0.04
(64.38%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 40 Thousand CAD | 0.0% |
2022 | 40 Thousand CAD | 0.0% |
2021 | 40 Thousand CAD | -96.01% |
2020 | 1 Million CAD | 4582.38% |
2019 | 21.39 Thousand CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | -100.0% |
2013 | 35.9 Thousand CAD | -75.82% |
2012 | 148.51 Thousand CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
2005 | - CAD | 0.0% |
2004 | - CAD | 0.0% |
2003 | - CAD | 0.0% |
2002 | - CAD | 0.0% |
2001 | - CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | -100.0% |
2023 Q2 | 40 Thousand CAD | 0.0% |
2023 FY | 40 Thousand CAD | 0.0% |
2023 Q4 | 40 Thousand CAD | 0.0% |
2023 Q3 | 40 Thousand CAD | 0.0% |
2023 Q1 | 40 Thousand CAD | 0.0% |
2022 Q2 | 40 Thousand CAD | 0.0% |
2022 FY | 40 Thousand CAD | 0.0% |
2022 Q4 | 40 Thousand CAD | 0.0% |
2022 Q3 | 40 Thousand CAD | 0.0% |
2022 Q1 | 40 Thousand CAD | 0.0% |
2021 Q2 | 40 Thousand CAD | 0.0% |
2021 Q1 | 40 Thousand CAD | -96.01% |
2021 Q3 | 40 Thousand CAD | 0.0% |
2021 FY | 40 Thousand CAD | -96.01% |
2021 Q4 | 40 Thousand CAD | 0.0% |
2020 Q1 | 824.28 Thousand CAD | 3753.62% |
2020 Q2 | 909.71 Thousand CAD | 10.36% |
2020 FY | 1 Million CAD | 4582.38% |
2020 Q3 | 955.63 Thousand CAD | 5.05% |
2020 Q4 | 1 Million CAD | 4.81% |
2019 Q1 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q4 | 21.39 Thousand CAD | 0.0% |
2019 FY | 21.39 Thousand CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q3 | - CAD | -100.0% |
2018 Q2 | 48.29 Thousand CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q1 | 16.48 Thousand CAD | 0.0% |
2015 Q2 | - CAD | -100.0% |
2015 FY | - CAD | 0.0% |
2014 Q2 | 32.97 Thousand CAD | -33.33% |
2014 Q4 | - CAD | -100.0% |
2014 Q1 | 49.46 Thousand CAD | 449.56% |
2014 FY | - CAD | -100.0% |
2014 Q3 | 16.48 Thousand CAD | -50.0% |
2013 FY | 35.9 Thousand CAD | -75.82% |
2013 Q4 | 9001.00 CAD | -89.08% |
2013 Q3 | 82.44 Thousand CAD | 129.6% |
2013 Q2 | 35.9 Thousand CAD | -81.37% |
2013 Q1 | 192.75 Thousand CAD | 10.33% |
2012 Q3 | 129 Thousand CAD | 0.0% |
2012 Q1 | 993.5 Thousand CAD | 0.67% |
2012 Q2 | - CAD | -100.0% |
2012 Q4 | 174.7 Thousand CAD | 35.43% |
2012 FY | 148.51 Thousand CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q4 | 986.85 Thousand CAD | 782.3% |
2011 Q3 | 111.85 Thousand CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 Q1 | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2006 Q3 | - CAD | 0.0% |
2006 Q4 | - CAD | 0.0% |
2006 Q2 | - CAD | 0.0% |
2006 Q1 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
2005 Q2 | - CAD | 0.0% |
2005 Q3 | - CAD | 0.0% |
2005 FY | - CAD | 0.0% |
2005 Q4 | - CAD | 0.0% |
2005 Q1 | - CAD | 0.0% |
2004 Q1 | - CAD | 0.0% |
2004 FY | - CAD | 0.0% |
2004 Q3 | - CAD | 0.0% |
2004 Q4 | - CAD | 0.0% |
2004 Q2 | - CAD | 0.0% |
2003 Q3 | 27.6 Thousand CAD | 0.0% |
2003 Q2 | - CAD | 0.0% |
2003 FY | - CAD | 0.0% |
2003 Q4 | - CAD | -100.0% |
2003 Q1 | - CAD | 0.0% |
2002 FY | - CAD | 0.0% |
2002 Q3 | - CAD | 0.0% |
2002 Q4 | - CAD | 0.0% |
2001 FY | - CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.24 Million USD | 98.214% |
Arrayit Corporation | 1.07 Million USD | 96.29% |
Atlantic International Corp. | 2.93 Million USD | 98.635% |
Biocept, Inc. | 12.1 Million USD | 99.67% |
Bioqual, Inc. | 3.58 Million USD | 98.885% |
CardioGenics Holdings Inc | 72.61 Thousand USD | 44.914% |
DermTech, Inc. | 54.39 Million USD | 99.926% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.992% |
HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 99.173% |
iMD Companies, Inc. | 1.12 Million USD | 96.429% |
IDenta Corp. | 789.14 Thousand USD | 94.931% |
Interpace Biosciences, Inc. | 11.19 Million USD | 99.643% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 43.84 Thousand USD | 8.77% |
Lumos Diagnostics Holdings Limited | 8.04 Million USD | 99.503% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 3.82 Million USD | 98.954% |
NovelStem International Corp. | 3.57 Million USD | 98.881% |
Optigenex Inc. | 8.94 Million USD | 99.553% |
PharmChem, Inc. | 77.35 Thousand USD | 48.289% |
Proteome Sciences plc | 17.15 Million USD | 99.767% |
Response Genetics, Inc | 6.37 Million USD | 99.372% |
Rennova Health, Inc. | 15.32 Million USD | 99.739% |
RushNet, Inc. | 4.82 Million USD | 99.171% |
ScreenPro Security Inc. | 207.03 Thousand USD | 80.68% |
Stella Diagnostics Inc. | 6.2 Million USD | 99.355% |
StageZero Life Sciences Ltd. | 1.8 Million USD | 97.778% |
Todos Medical Ltd. | 38.34 Million USD | 99.896% |